{"id":"NCT00578929","sponsor":"Alcon Research","briefTitle":"Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients","officialTitle":"Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-11","completion":null,"firstPosted":"2007-12-21","resultsPosted":"2010-02-09","lastUpdate":"2010-03-02"},"enrollment":2388,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Olopatadine Hydrochloride Nasal Spray 0.6%","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"Olopatadine 0.6% 1 Spray","type":"EXPERIMENTAL"},{"label":"Vehicle 1 spray","type":"PLACEBO_COMPARATOR"},{"label":"Olopatadine 0.6% 2 sprays","type":"EXPERIMENTAL"},{"label":"Vehicle 2 sprays","type":"PLACEBO_COMPARATOR"}],"summary":"A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.","primaryOutcome":{"measure":"Percent Change From Baseline in the Reflective Total Nasal Symptom Score (TNSS)","timeFrame":"Baseline through 2 weeks after randomization","effectByArm":[{"arm":"Olopatadine 0.6% 1 Spray","deltaMin":-25.1,"sd":1.45},{"arm":"Vehicle 1 Spray","deltaMin":-18.17,"sd":1.45},{"arm":"Olopatadine 0.6% 2 Sprays","deltaMin":-26.35,"sd":1.45},{"arm":"Vehicle 2 Sprays","deltaMin":-21.21,"sd":1.45}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21477426"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":298},"commonTop":["Headache","Epistaxis"]}}